共 50 条
- [1] The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancerEUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (20) : 7679 - 7686Karadag, IKarakaya, S.Yilmaz, M. E.Oksuzoglu, O. B. Cakmak
- [2] The Baseline Pan-Immune-Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System LymphomaJOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 5347 - 5363Duan, LingGuo, WenhuiYin, ShuoYang, ShouboLiu, JieDuan, YunyunDong, GehongLi, WenbinChen, Feng
- [3] Response to chemotherapy and treating institution predict survival in primary central nervous system lymphomaBRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) : 177 - 183Korfel, AMartus, PNowrousian, MRHossfeld, DKKirchen, HBrücher, JStelljes, MBirkmann, JPeschel, CPasold, RFischer, LJahnke, KThiel, E
- [4] Survival outcomes and treatment experience of 124 patients with primary central nervous system lymphomaSTRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (09) : 760 - 773Tang, ZiqingWu, GetingTan, FangLong, YangHong, JidongLyu, ZhipingWei, Rui
- [5] A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)BLOOD, 2020, 136Ali, Omer M.Nalawade, Sahil S.Xi, YinWagner, BenMazal, AlexanderAhlers, ShaneRizvi, Syed M.Awan, Farrukh T.Kumar, Kiran A.Desai, Neil B.Maldjian, Joseph A.Pinho, Marco C.Geethakumari, Praveen Ramakrishnan
- [6] The impact of tumor resection on survival and functional outcomes for patients with primary central nervous system lymphomaCLINICAL NEUROLOGY AND NEUROSURGERY, 2024, 246Nien, Ju-EnChuang, Chi-ChengHsu, Peng-WeiHuang, Yin-ChengTsai, Hong-ChiehChen, Pin-YuanLee, Cheng-ChiLu, Yu-JenLin, Ya-JuiWei, Kuo-ChenChen, Ko-Ting
- [7] CRANIOTOMY AND SURVIVAL FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMANEURO-ONCOLOGY, 2017, 19 : 239 - 239Rae, AliMehta, AmolCloney, MichaelKinslow, ConnorWang, TonyBhagat, GovindCanoll, PeterZanazzi, GeorgeSisti, MichaelSheth, SameerConnolly, E. SanderMcKhann, Guy, IIBruce, JeffreyIwamoto, FabioSonabend, Adam M.
- [8] Craniotomy and Survival for Primary Central Nervous System LymphomaNEUROSURGERY, 2019, 84 (04) : 935 - 943Rae, Ali I.Mehta, AmolCloney, MichaelKinslow, Connor J.Wang, Tony J. C.Bhagat, GovindCanoll, Peter D.Zanazzi, George J.Sisti, Michael B.Sheth, Sameer A.Connolly, E. SanderMcKhann, Guy M.Bruce, Jeffrey N.Iwamoto, Fabio M.Sonabend, Adam M.
- [9] Prognostic factors and score for response and survival in primary central nervous system lymphoma from a randomized phase III trialONKOLOGIE, 2011, 34 : 296 - 296Jahnke, K.Martus, P.Lokka, S.Moehle, R.Griesinger, F.Rauch, M.Roeth, A.Hertenstein, B.Fischer, T.Hundsberger, T.Mergenthaler, H. -GLeithaeuser, M.Birnbaum, T.Herrlinger, U.Schubert, J.Florschuetz, A.Fischer, L.Weller, M.Thiel, E.Korfel, A.
- [10] Therapeutic and survival outcomes following treatment of primary central nervous system lymphoma: a 12-year case studyJOURNAL OF NEUROSURGICAL SCIENCES, 2014, 58 (03) : 183 - 190Sitthinamsuwan, B.Rujimethapass, S.Chinthammitr, Y.Treetipsatit, J.